# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-339076
Filing Date
2026-08-07
Accepted
2026-08-07 06:45:42
Documents
107
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cgc-20260630.htm iXBRL | 10-Q | 2805380
2 | EX-31.1 | cgc-ex31_1.htm | EX-31.1 | 17829
3 | EX-31.2 | cgc-ex31_2.htm | EX-31.2 | 17581
4 | EX-32.1 | cgc-ex32_1.htm | EX-32.1 | 10775
5 | EX-32.2 | cgc-ex32_2.htm | EX-32.2 | 10781
| Complete submission text file | 0001193125-26-339076.txt |  | 14296235

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | cgc-20260630.xsd | EX-101.SCH | 2449255
110 | EXTRACTED XBRL INSTANCE DOCUMENT | cgc-20260630_htm.xml | XML | 2708737

Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38496 | Film No.: 261251335
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)